We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BHE icon
2626
Benchmark Electronics
BHE
$2.92B
$78K ﹤0.01%
2,748
-13,366
-83% -$403K
BRY
2627
DELISTED
Berry Corp
BRY
$78K ﹤0.01%
11,675
+4,575
+64% +$28.9K
CZNC icon
2628
Citizens & Northern Corp
CZNC
$454M
$78K ﹤0.01%
3,166
+1,833
+138% +$45K
PRAX icon
2629
Praxis Precision Medicines
PRAX
$10.2B
$78K ﹤0.01%
286
+217
+314% +$77.7K
RRC icon
2630
Range Resources
RRC
$9.41B
$78K ﹤0.01%
4,642
-50,437
-92% -$633K
WEYS icon
2631
Weyco Group
WEYS
$441M
$78K ﹤0.01%
3,511
+2,721
+344% +$58.3K
LEVL
2632
DELISTED
Level One Bancorp, Inc. Common Stock
LEVL
$78K ﹤0.01%
2,860
+1,783
+166% +$48K
ACR
2633
ACRES Commercial Realty
ACR
$101M
$77K ﹤0.01%
4,789
+4,718
+6,645% +$75.2K
ANIX icon
2634
Anixa Biosciences
ANIX
$111M
$77K ﹤0.01%
+19,979
New +$85.1K
ASMB icon
2635
Assembly Biosciences
ASMB
$530M
$77K ﹤0.01%
1,650
+1,391
+537% +$68.9K
ASTE icon
2636
Astec Industries
ASTE
$991M
$77K ﹤0.01%
1,223
-504
-29% -$35.2K
ERO icon
2637
Ero Copper
ERO
$3.81B
$77K ﹤0.01%
+3,699
New +$75.4K
GKOS icon
2638
Glaukos
GKOS
$10.7B
$77K ﹤0.01%
914
-5,449
-86% -$447K
HESM icon
2639
Hess Midstream
HESM
$5.21B
$77K ﹤0.01%
3,040
-10,084
-77% -$243K
ICLN icon
2640
iShares Global Clean Energy ETF
ICLN
$2.08B
$77K ﹤0.01%
+3,275
New +$74.7K
IOSP icon
2641
Innospec
IOSP
$2.29B
$77K ﹤0.01%
845
-368
-30% -$36.5K
KNSA icon
2642
Kiniksa Pharmaceuticals
KNSA
$5.97B
$77K ﹤0.01%
5,501
+4,167
+312% +$63.3K
NRIX icon
2643
Nurix Therapeutics
NRIX
$2.69B
$77K ﹤0.01%
2,910
-686
-19% -$20.1K
PRTS icon
2644
CarParts.com
PRTS
$51.2M
$77K ﹤0.01%
380
-290
-43% -$48.5K
STBA icon
2645
S&T Bancorp
STBA
$1.79B
$77K ﹤0.01%
2,460
+125
+5% +$4.14K
SP
2646
DELISTED
SP Plus Corporation
SP
$77K ﹤0.01%
2,513
-868
-26% -$28.4K
KBAL
2647
DELISTED
Kimball International
KBAL
$77K ﹤0.01%
5,818
+4,477
+334% +$61K
FMBI
2648
DELISTED
First Midwest Bancorp Inc/IL
FMBI
$77K ﹤0.01%
3,884
-6,952
-64% -$146K
DAKT icon
2649
Daktronics
DAKT
$1.03B
$76K ﹤0.01%
11,486
-1,763
-13% -$11.5K
DOYU
2650
DouYu International Holdings
DOYU
$134M
$76K ﹤0.01%
1,118
+1,088
+3,627% +$93.6K

Similar funds

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.